FDA Approved: VANFLYTA — Original Application (Daiichi Sankyo Inc.)

View source ↗

Summary

FDA approved VANFLYTA (quizartinib) for adults with newly diagnosed FLT3-ITD–positive acute myeloid leukemia in combination with standard induction and consolid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VANFLYTA (quizartinib)

Snippet

ORIG AP for VANFLYTA (QUIZARTINIB)